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OBJECTIVES We studied the acute effects of cardiac resynchronization therapy (CRT) on functional mitral
regurgitation in heart failure (HF) patients with left bundle branch block (LBBB).
BACKGROUND Both a decrease in left ventricular (LV) closing force and mitral valve tethering have been
implicated as mechanisms for functional mitral regurgitation (FMR) in dilated hearts. We
hypothesized that an increase in LV closing force achieved by CRT could act to reduce FMR.
METHODS Twenty-four HF patients with LBBB and FMR were studied after implantation of a
biventricular CRT system. Acute changes in FMR severity between intrinsic conduction
(OFF) and CRT were quantified according to the proximal isovelocity surface area method
by measuring the effective regurgitant orifice area (EROA). Results were compared with the
changes in estimated maximal rate of left ventricular systolic pressure rise (LVdP/dtmax) and
transmitral pressure gradients (TMP), both measured by Doppler echocardiography.
RESULTS Cardiac resynchronization therapy was associated with a significant reduction in FMR
severity. Effective regurgitant orifice area decreased from 25 19 mm2 (OFF) to 13 8 mm2
(CRT). The change in EROA was directly related to the increase in LVdP/dtmax (r 
0.83, p  0.0001). Compared with OFF, TMP increased more rapidly during CRT, and
a higher maximal TMP was observed (OFF 73 24 mm Hg vs. CRT 85 26 mm Hg, p
0.01).
CONCLUSIONS Functional mitral regurgitation is reduced by CRT in patients with HF and LBBB. This
effect is directly related to the increased closing force (LVdP/dtmax). The results support the
hypothesis that an increase in TMP, mediated by a rise in LVdP/dtmax due to more
coordinated LV contraction, may facilitate effective mitral valve closure. (J Am Coll Cardiol
2003;41:765–70) © 2003 by the American College of Cardiology Foundation
Functional mitral regurgitation (FMR) in dilated cardiomy-
opathy (DCM) results from an imbalance between the
closing and the tethering forces that act on the mitral valve
leaflets (1). Ventricular dilation and increased chamber
sphericity increase the distance between the papillary mus-
cles to the enlarged mitral annulus as well as to each other,
restricting leaflet motion and increasing the force needed for
effective mitral valve closure (1–4). This mitral valve closing
force is determined by the systolic left ventricular (LV)-left
atrial pressure difference, that is, the transmitral pressure
gradient (TMP). In vitro studies have demonstrated that
increasing TMP can decrease the effective regurgitant ori-
fice area (EROA), but isolating this effect is difficult in the
clinical and even in the experimental setting. Recoordina-
tion of LV contraction by cardiac resynchronization therapy
(CRT) with biventricular pacing may increase the maximal
rate of LV systolic pressure rise (LVdp/dtmax) (5) and,
thus, increase TMP acutely (6). Therefore, it offers a unique
opportunity to study the effect of an acute increase in TMP
on mitral valve competence, irrespective of loading condi-
tions and reverse remodeling, which may occur during
chronic pacing therapy. We hypothesized that CRT in-
creases LVdp/dtmax and, consequently, TMP and, thus,
decreases mitral valve EROA. This was tested in a consec-
utive group of patients with severe LV dysfunction, left
bundle branch block (LBBB), and FMR using continuous
wave (CW) Doppler echocardiography and color Doppler
flow mapping of the proximal flow convergence region.
METHODS
Patients. We studied 24 consecutive patients presenting
with severely impaired LV systolic function (transthoracic
biplane ejection fraction [EF] 30%), LBBB (QRS 120
ms), and FMR measured by color Doppler echocardiogra-
phy. All patients received a biventricular pacing device for
CRT with a right ventricular apical lead and LV pacing
electrodes implanted through the coronary sinus and posi-
tioned in an LV epicardial vein. Informed consent was
obtained from all patients before the echocardiographic
examination with acute reprogramming of the pacemakers.
Echocardiography protocol. Transthoracic echocardiog-
raphy was performed in the first week after implantation of
the CRT system or before the onset of active CRT. All
patients underwent a standard two-dimensional and Dopp-
ler echocardiographic examination at rest in the left lateral
supine position during intrinsic conduction, no pacing
(OFF) and CRT. Left ventricular end-diastolic volume
(ml), end-systolic volume (ml), and EF (%) were measured
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by biplane Simpson’s rule during OFF. Reprogramming of
the pacemakers to each mode (OFF and CRT) was per-
formed during the echocardiography examination without
patient movement. The examinations were performed with
broadband transducers and second harmonic imaging on
different ultrasound scanners (Sonos 5500, Agilent,
Andover, Massachusetts; Vivid V and Vivid VII, GE
Vingmed Ultrasound, Horten, Norway). All results repre-
sent averages of three measurements in different cardiac
cycles.
Echocardiographic analysis. The proximal isovelocity sur-
face area (PISA) method is based on the principle of flow
convergence and assumes that flow proximal to the regur-
gitant orifice is equal to the flow through the regurgitant
orifice (7). Progressive acceleration of the regurgitant blood
produces shells of identical velocities proximal to the orifice.
The radius of a discrete shell (r) can be measured after a
baseline shift of the color flow to decrease the aliasing
velocity (Valias). The baseline was shifted to achieve a Valias
near 40 cm/s. Assuming a hemispherical shape, regurgitant
flow (RegFlow, cm3/s) was calculated as: RegFlow 2 
 r2  Valias. The EROA (mm
2) is an index of regurgita-
tion severity (8) and was calculated by: EROA (mm2) 
RegFlow/maximal mitral regurgitant velocity ([MRVmax]
m/s), where MRVmax was defined as the maximal velocity of
the mitral regurgitant jet obtained by CW Doppler.
Changes in EROA between OFF and CRT were expressed
as the percent difference from OFF ( EROA, %). Addi-
tional measurement of the CW mitral regurgitant velocity
time integral ([MRVTI] cm) allows calculation of regurgi-
tant volume ([RegVol] ml) by: RegVol (ml)  EROA
(mm2)  MRVTI (cm)/100.
The TMP was defined as the LV to left atrial pressure
drop across the mitral valve. During systole, the rise in TMP
counteracts the tethering forces of the papillary muscles and
leads to mitral valve closure. In the presence of mitral
regurgitation, maximal TMP (TMPmax) can be estimated
from CW Doppler tracings of the mitral regurgitant jet
using the simplified Bernoulli equation as 4  (MRVmax)
2.
To further quantify the dynamic changes with CRT, we
measured the transmitral pressure gradient 100 ms after
onset of the FMR jet (TMP100) and the total duration of
FMR, excluding any presystolic mitral regurgitation.
The LVdP/dtmax was used as an index for LV systolic
function and estimated noninvasively from the steepest
rising segment of the CW Doppler mitral regurgitation
velocity curve as described previously (9). The change in
LVdP/dtmax between OFF and CRT was expressed as the
percent difference from OFF (LVdP/dtmax, %) (Fig. 1).
During OFF and CRT, LV end-diastolic and end-
systolic volumes were calculated from the apical four- and
two-chamber views according to biplane modified Simp-
son’s rule. To quantify changes in LV shape, we calculated
the LV sphericity index as the ratio of LV end-diastolic
volume and the volume of a sphere with a diameter equal to
the LV end-diastolic long axis (10,11). Systolic mitral leaflet
deformation (mitral leaflet tenting area) was measured by
the area enclosed between the annular plane and mitral
leaflets, measured from the parasternal long-axis view (2).
Statistical analysis. Continuous data are expressed as mean
values  SD. Paired data were analyzed with Wilcoxon
signed rank test. A p value of 0.05 was considered
significant for all comparisons. The relation between
EROA and LVdP/dtmax was analyzed with linear
regression analysis. Reproducibility of Doppler time interval
measurements and PISA radius was assessed in the first 10
consecutive patients as the mean difference between two
independent measurements performed on different occa-
sions by one observer (intraobserver variability) and between
two independent observers (interobserver variability). The
results were expressed as percentages of the first measure-
ment ( SD). The analysis was performed using StatsDi-
rect v.1.605 (CamCode, Ashwell, United Kingdom).
RESULTS
Clinical patient characteristics are presented in Table 1. All
patients were in stable sinus rhythm. Ventricular pacing was
performed in an atrial triggered mode with a mean atrio-
ventricular delay of 109  18 ms. Biventricular pacing
acutely decreased mitral regurgitation severity and improved
LV systolic function as measured by LVdP/dtmax and EF,
with no change in heart rate (Table 2). In 23 of 24 patients,
EROA decreased (Fig. 2), and EROA was directly related
to the increase in LVdP/dtmax (Fig. 3). The improved
LVdP/dtmax resulted in an increase of TMPmax from 73
Abbreviations and Acronyms
CAD  coronary artery disease
CRT  cardiac resynchronization therapy
CW  continuous wave
DCM  dilated cardiomyopathy
EF  ejection fraction
EROA  effective regurgitant orifice area
FMR  functional mitral regurgitation
LBBB  left bundle branch block
LV  left ventricle/ventricular
LVdP/dtmax  maximal rate of left ventricular systolic
pressure rise
MRVmax  maximal velocity of the mitral
regurgitant jet obtained by continuous
wave Doppler
MRVTI  mitral regurgitant velocity time integral
OFF  intrinsic conduction, no pacing
PISA  proximal isovelocity surface area
RegFlow  regurgitant flow
RegVol  regurgitant volume
TMP  transmitral pressure gradient
TMP100  transmitral pressure gradient 100 ms
after onset of the functional mitral
regurgitation jet
TMPmax  maximal transmitral pressure gradient
Valias  aliasing velocity
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24 mm Hg (OFF) to 85  26 mm Hg (CRT, p  0.01 vs.
OFF) and of TMP100 from 41  17 mm Hg (OFF) to 61
 18 mm Hg (CRT, p  0.0001 vs. OFF). A significant,
although weak, linear correlation was found between
EROA and TMP100 (EROA  0.54  TMP100
24.8, r  0.44, p  0.03), but not between EROA
and TMPmax (EROA  0.57  TMPmax 33.8,
r  0.2, p  NS). The duration of FMR decreased from
478  77 ms (OFF, 62  12% of cycle length) to 444  57
ms (CRT, 57  8% of cycle length, p  0.02 vs. OFF).
No significant relationship was observed between baseline
FMR severity and end-diastolic volume, QRS width, and
LV sphericity index. There were also no significant differ-
ences observed between patients with coronary artery dis-
ease (CAD) and with DCM for EROA (DCM: 48 
21% vs. CAD: 31 25%, p NS) and for LVdP/dtmax
(DCM: 46 28% vs. CAD: 40 28%, pNS). Increased
LV chamber sphericity was documented by a sphericity
index of 0.56  0.13, but was not significantly affected by
CRT (0.58  0.14, p  NS vs. OFF). Midsystolic mitral
leaflet tenting area was smaller during CRT (6.21  2.04
cm2 [OFF] vs. 5.52  1.72 cm2 [CRT], p  0.02). There
was no significant correlation between the mitral leaflet
tenting area and EROA.
Inter- and intraobserver variability. The mean percent
errors for measurements of Doppler time intervals and
velocities were 3  2% and 4  2% for the same observer
and 5 3% and 5 4% between two blinded observers. For
measurement of the PISA radius, the intra- and interob-
server variabilities were 6  5% and 7  5%, respectively.
DISCUSSION
The present study demonstrates that CRT can acutely
reduce the severity of FMR in heart failure patients with an
LBBB, irrespective of the potential long-term reverse re-
modeling effect on LV shape and size (12,13). Furthermore,
Table 1. Clinical Characteristics of the Study Population
(n  24)
Gender (male/female) 19/5
Age (yrs) 63  10
CAD/DCM 12/12
NYHA functional class (III/IV) 23/1
PR interval (ms) 181  41
QRS width (ms) 176  25
EDV (ml) 259  98
ESV (ml) 208  90
EF (%) 21  6
Plus minus values are means  SD.
CAD  coronary artery disease; DCM  dilated cardiomyopathy; EDV 
end-diastolic volume; EF ejection fraction; ESV end-systolic volume; NYHA
New York Heart Association.
Figure 1. Continuous wave (CW) Doppler regurgitant jet in a study patient before (left) and after cardiac resynchronization therapy (CRT) (right).
Maximal rate of left ventricular systolic pressure rise (LVdP/dtmax) is estimated by measuring the time interval between 1 m/s and 3 m/s on the downslope
of the CW Doppler spectrum (solid lines). Estimated LVdP/dtmax rises from approximately 510 mm Hg/s (approximately 63 ms) to approximately 720
mm Hg/s (approximately 44 ms), and transmitral pressure gradient peak occurs earlier in systole (arrows). Duration of functional mitral regurgitation
(excluding the presystolic component) decreases from 435 ms (OFF) to 382 ms (CRT).
Table 2. Effects of CRT on Echocardiographic Parameters
No CRT CRT p Value
Heart rate (beats/min) 79  14 78  13 p  NS
EDV (ml) 259  98 263  98 p  NS
ESV (ml) 208  90 198  85 p  0.05
EF (%) 21  6 26  9 p  0.01
RegFlow (cm3/s) 100  67 59  35 p  0.001
EROA (mm2) 25  19 13  8 p  0.001
RegVol (ml/beat) 32  19 19  9 p  0.001
LVdP/dtmax (mm Hg/s) 634  349 867  396 p  0.001
CRT  cardiac resynchronization therapy; EDV  end-diastolic volume; EF 
ejection fraction; EROA  effective regurgitant orifice area; ESV  end-systolic
volume; LVdP/dtmax  maximal rate of left ventricular systolic pressure rise;
RegFlow  regurgitant flow; RegVol  regurgitant volume.
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the reduction in FMR is quantitatively related to an increase
in LVdP/dtmax and TMP. We observed an immediate
reduction in mean EROA and RegVol of about 40% by
CRT.
Mechanistic insights. Prior studies demonstrated that the
presence of FMR in heart failure is strongly dependent on
alterations in LV shape, as the tethering forces that act on
the mitral leaflets are higher in dilated, more spherical
ventricles (14). These geometric changes alter the balance
between tethering and closing forces and impede effective
mitral valve closure. Under these conditions, the mitral
regurgitant orifice area will be largely determined by the
phasic changes in TMP (15–17), and worsening of LV
dysfunction with a delayed LV rate of pressure rise will
further increase FMR severity due to the impaired closing
force. Consequently, it has been suggested that therapeutic
interventions aimed to improve TMP should be able to
reduce FMR severity (17). Our study represents a direct
therapeutic application of this concept and demonstrates
that an increase in TMP, mediated by a rise in LVdP/
dtmax, may oppose the increased mitral leaflet tethering
forces in DCM and facilitate more effective mitral valve
closure. Cardiac resynchronization therapy caused both an
increase in peak transmitral closing force (TMPmax) as well
as an accelerated rise in TMP during the isovolumic
contraction phase, as reflected by the increase in TMP100.
The accelerated rise in TMP effectively counteracted the
increased tethering forces that impair mitral valve compe-
tence (Fig. 4) and decreased acutely midsystolic mitral
leaflet tenting area.
Cause-effect relationship of increase in dP/dt and de-
crease in EROA. In normal subjects, LVdP/dtmax drops
abruptly with aortic valve opening, as contraction is trans-
lated into moving blood rather than raising pressure. It
could, therefore, be argued that in patients with mitral
regurgitation the decrease in EROA by CRT might have
raised LVdP/dtmax by preventing early ventricular con-
traction force to be translated into motion (regurgitation)
instead of pressure. In this case, the increase in LVdP/
dtmax would be the effect rather than the cause of a decrease
in EROA. However, animal experiments in which ischemic
mitral regurgitation was abolished by chordal cutting (18)
have not found any significant change in LVdP/dtmax.
We, therefore, believe that CRT increases LVdP/dtmax,
which, in turn, decreases EROA. The concept that the
Doppler-derived LVdP/dtmax, which represents the rate
of rise of the LV-left atrial pressure difference, is the cause
(rather than the effect) of the decrease in EROA is further
supported by experimental studies, which have demon-
strated that the rate of rise of the transmitral closing force
effectively determines the size of the EROA (17).
Influence of LV geometry on FMR severity. The fact
that LV sphericity, which was pathologic in all our patients,
was not acutely affected by CRT further underscores the
notion that the reduction in EROA was independent of a
change in LV geometry. However, such a reverse remodel-
ing process may be observed chronically and, thus, may
contribute to a further decrease in FMR severity by
CRT (2).
Although systolic mitral valvular tenting is a major
determinant of EROA, we found no significant correlation
between mitral deformation and FMR severity in our
patient population, which is in contrast with previous
reports (2). This apparent disagreement might be explained
by the high prevalence of ventricular asynchrony in our
study as we included only patients with significant electrical
Figure 2. Individual changes in effective regurgitant orifice area (EROA)
(mm3) between baseline (OFF) and cardiac resynchronization therapy
(CRT); EROA showed a wide range during OFF and decreased with CRT
in 23 patients. A small increase in EROA was observed in one patient with
mild regurgitation during OFF (dashed line).
Figure 3. The decrease in effective regurgitant orifice area (EROA),
displayed as the percent change between OFF and cardiac resynchroniza-
tion therapy (CRT), was directly correlated to the increase in left
ventricular systolic function, as measured by the percent increase in
maximal rate of left ventricular systolic pressure rise (LVdP/dtmax):
EROA  0.7  LVdP/dtmax 7.6, r  0.83, p  0.0001.
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conduction delays, which show a large degree of ventricular
wall motion asynchrony (19). The individual degree of
ventricular asynchrony might, independently of the LV
geometry, alter the leaflet tethering forces and aggravate
FMR. As experimental studies convincingly demonstrate, it
is not isolated papillary muscle dysfunction per se that
causes FMR (20,21), but altered papillary displacement by
dysfunction and remodeling of the underlying myocardium
(22,23). Thus, asynchronous activation of the medial and
lateral segments supporting the papillary muscles might
independently contribute to FMR severity in heart failure.
Whether resynchronization of this disturbed activation
sequence would favorably affect FMR independently of an
associated increase in LVdP/dtmax requires further inves-
tigations.
Clinical implications. Several trials demonstrated success-
ful treatment of FMR in patients with heart failure and
suggested that EROA reduction is the main mechanism for
improvement. Beside pharmacologic afterload reduction
(24), surgical mitral annuloplasty has been shown to be
effective in correcting mitral regurgitation in end-stage
cardiomyopathy (25). Other groups demonstrated that sur-
gical reduction of ventricular dilation may reduce FMR,
even without concomitant mitral valve repair (26). Our
present results confirm earlier suggestions that LV systolic
function plays a crucial role in the pathogenesis of FMR
(1,17,27) and that the restoration of an adequate closing
force is as relevant as surgical correction of ventricular
geometry and mitral annular dimensions.
STUDY LIMITATIONS
The applied PISA method assumes that the convergence
zone is hemispherical. Recent studies have demonstrated
that mitral valve orifice shape is rather elliptic or slit-like
(28). Although a hemielliptical formula may, therefore, be
more suitable to describe this situation than a simplified
hemispherical formula, the current method has been exten-
sively validated in the clinical setting and found to be both
accurate and reproducible (29). Moreover, because we fo-
cused on the intraindividual changes in FMR with CRT,
this limitation is unlikely to have affected the principle
results of the study. Although the mitral regurgitant orifice
is dynamic (15,16), midsystolic EROA appears to be a
robust surrogate of mean EROA (30).
Estimation of LV dP/dtmax with the described CW
Doppler technique tends to underestimate true LVdp/
dtmax because it calculates the mean rise in LV pressure
during the isovolumic contraction phase rather than the true
maximum instantaneous pressure rise (31). Despite this
small systematic error, the method is reproducible and even
valuable for the prediction of prognosis in patients with
dilative cardiomyopathy and CRT (32).
We did not systematically measure arterial blood pressure
in this study, and, thus, no direct conclusions can be made
on the possible changes in left atrial pressure. However, it is
most likely that the measured increase in TMPmax reflects
the previously observed increase in systolic arterial blood
pressure with CRT (5,6). Our study is, furthermore, limited
to acute measurements, and no conclusions can be drawn
concerning the long-term effects of CRT on FMR severity.
This has been studied by previous researchers, who demon-
strated that long-term CRT may reduce FMR severity
(33,34).
CONCLUSIONS
Cardiac resynchronization therapy in selected patients with
advanced heart failure and electrical conduction delay
acutely reduces the severity of FMR by decreasing the
EROA. This effect is directly related to an improvement in
LV systolic function causing an accelerated rise in TMP,
which effectively counteracts the increased tethering forces
that impair mitral valve competence. The acute effect is
Figure 4. Schematic representation of the relationship between the in-
crease in transmitral pressure gradient (TMP) (the instantaneous difference
between left ventricular and left atrial pressure) and the decrease in effective
regurgitant orifice area (EROA). During OFF (top panel), left ventricular
(LV) contractility is low and results in a slow rise in the LV pressure curve
and TMP with a relatively late systolic maximum. Due to the slow LV
pressure rise with delayed development of an effective transmitral closing
force (approximately TMP), EROA remains large for a relatively long
period until it finally reaches its minimal value. In contrast, during cardiac
resynchronization therapy (CRT) (bottom panel), LV contractility im-
proves, TMP rises faster and to a higher maximal value, which is also
reached earlier. Consequently, the reduction in EROA occurs earlier,
EROA reaches lower values and for a prolonged period of time. The
shaded area represents the time in systole during which EROA is below
50% of its initial value. Note that, in the chosen example, the reduction in
the height of the V-wave after a decrease in the initial mitral regurgitation
will contribute to a preserved TMP during the latter half of systole. Solid
line  left atrial (LA) and LV pressure; dotted line  EROA. Adapted
from Hung et al. (15).
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independent from geometrical changes (reverse remodeling)
and may exert further beneficial effects on FMR severity.
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